HeartSine

Executive Summary

HeartSine Technologies, a Northern Irish medical device company founded in 1997, specializes in compact and user-friendly automated external defibrillators (AEDs) for emergency cardiac care. Acquired by Stryker, the company operates as a subsidiary within the global medical technology leader, benefiting from Stryker's extensive distribution network and resources. HeartSine's product portfolio focuses on ease of use and affordability, positioning it well in the public access and workplace AED markets. The company's strategic alignment with Stryker enhances its ability to penetrate new geographies and expand market share, particularly as awareness of sudden cardiac arrest and the importance of early defibrillation grows. While HeartSine operates in a competitive landscape dominated by larger players like Philips and ZOLL, its niche in cost-effective, portable AEDs and its integration with Stryker's broader medical device ecosystem provide a solid foundation for continued growth.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance or CE marking of next-generation AED with enhanced connectivity and real-time feedback70% success
• Q2 2027Expansion into new emerging markets through Stryker's distribution channels60% success
• Q1 2027Publication of clinical study demonstrating improved survival rates with HeartSine AEDs in public settings50% success